The story of Viagra, and its developer copyright, presents a intriguing case study for investors. Originally a blockbuster drug, yielding billions in revenue , its patent expiration created a deluge of generic competition , significantly eroding its market share . While certain pharmaceutical companies may seek to capitalize on related treatments ,